Liver Transplantation clinical trials
33 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
- Immune Tolerance Induction After Liver Transplantation
- Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool
- Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
- Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
- Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation
- EVR and EPO for Liver Transplant Tolerance
- Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
- Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
- Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue
- Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
- High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
- Viability Assessment Using FMN Measured in Perfusate and Bile During Normothermic Machine Perfusion
- Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
- US National OCS Liver Perfusion (OLP) Registry
- Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
- The Mycophenolate Pregnancy Registry
- Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
- Health Advocate for Children After Liver Transplant
- HEalth Advocate for Liver Transplant - Pilot
- HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients
- Mediterranean Diet Post-liver Transplantation
- Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications
- Peer Support for Liver Transplant Recipients With History of ALD
- Fibrinogen in Liver Transplant
- Letermovir for R+ Study
- Prospective Observational Multimodal Neuromonitoring During High-Risk Adult Surgery
- Intervention for Alcohol Use Disorder Recovery After Liver Transplantation
- Rezafungin Prophylaxis in Liver Transplant
- Global Utilization And Registry Database for Improved preservAtion of doNor Livers
- VitaSmart HOPE System: Bridge to HOPE Registry
- Liver Transplant CGM
- Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Liver Transplantation” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.